Medscape News, April 29, 2021: Two more cancer indications that had been granted accelerated approval by the US Food and Drug Administration (FDA) are going to stay in place, at least for now. This was the verdict after the second day of a historic 3-day meeting (April 27–29) and follows a similar verdict from day one.
Read More »Author: Caroline Bradford
Can California’s public universities mandate COVID-19 vaccines?
Monterey Herald, April 26, 2021: Dr. Diana Zuckerman and Robert Kaplan address the possibility of mandatory vaccinations at California public colleges and strategies to ensure policies can withstand legal choices.
Read More »Conflicts Galore: Upcoming Accelerated Approval Cancer Panel Includes Many Industry Relationships
Pink Sheet, April 21, 2021. Six members of the FDA Oncologic Drugs Advisory Committee had conflicts of interest requiring waivers to participate in the agency’s April 2021 meeting to review whether 3 cancer drugs should have their indications for late-stage breast cancer, bladder cancer, and gastric cancer removed from the market due to lack of evidence that they are effective.
Read More »Letter to California State Assembly Supporting Repeal of Sugary Drink Tax Preemption
March, 26, 2021: NCHR letter to California State Assembly supports the repeal of the sugary drink tax preemption to allow localities to implement life-saving taxes.
Read More »‘Buyer beware’: Ads hide PFAS cookware risks
E & E News, March 24, 2021: Consumers trying to avoid toxic chemicals in their nonstick cookware face convoluted advertising claims that can confuse even the most well-informed buyers. Take Diana Zuckerman, who, as president of the National Center for Health Research, is more familiar than the average person with chemistry and toxicology. Still, she said, trying to determine which pans and cookware did not contain PFAS, a class of toxic substances linked to cancer and other health problems, was no easy task.
Read More »